Immunotherapy and Targeted Therapies Efficacy in Thymic Epithelial Tumors: A Systematic Review

Immunotherapy and Targeted Therapies Efficacy in Thymic Epithelial Tumors: A Systematic Review

Background: Thymic epithelial tumors (TET) are rare neoplasms of the anterior mediastinum. Surgery is the mainstay treatment for resectable TET, whereas systemic treatments are reserved for unresectable and metastatic tumors. The development of new treatments, such as immune checkpoint inhibitors (I...

Full description

Bibliographic Details
Main Authors:	Apostolos C. Agrafiotis, Mariana Brandão, Thierry Berghmans, Valérie Durieux, Christiane Jungels
Format:	Article
Language:	English
Published:	MDPI AG 2023-10-01
Series:	Biomedicines
Subjects:	immunotherapy targeted therapies thymoma thymic carcinoma tumor microenvironment
Online Access:	https://www.mdpi.com/2227-9059/11/10/2722

Similar Items

Tumor Microenvironment in Thymic Epithelial Tumors: A Narrative Review
by: Apostolos C. Agrafiotis, et al.
Published: (2022-12-01)

An Overview of the Use of Anti-Angiogenic Agents in the Treatment of Thymic Epithelial Tumors
by: Apostolos C. Agrafiotis, et al.
Published: (2023-12-01)

Research Status of Molecular Targeted Therapy in Thymic Epithelial Tumors
by: Lizhu CHEN, et al.
Published: (2014-06-01)

Balancing the Risk of Adverse Events against the Efficacy of Immunotherapy in Advanced Thymic Epithelial Tumors
by: Birte Ohm, et al.
Published: (2022-12-01)

Occurrence of thymic pathology in two families. Is familial screening justified?
by: Sotirios D. Moraitis, et al.
Published: (2018-09-01)

Current Treatment Approaches for Thymic Epithelial Tumors
by: Alfredo Tartarone, et al.
Published: (2023-05-01)

Brief Report: High Levels of CD47 Expression in Thymic Epithelial Tumors
by: Thomas Yang Sun, MD, MHS, et al.
Published: (2023-04-01)

Immunotherapy for Thymomas and Thymic Carcinomas: Current Status and Future Directions
by: Arun Rajan, et al.
Published: (2024-03-01)

Prognostic factors and genetic markers in thymic epithelial tumors: A narrative review
by: Apostolos C. Agrafiotis, et al.
Published: (2022-12-01)

Immunobiology of Thymic Epithelial Tumors: Implications for Immunotherapy with Immune Checkpoint Inhibitors
by: Valentina Tateo, et al.
Published: (2020-11-01)

Efficacy and toxicities of gemcitabine and cisplatin combined with endostar in advanced thymoma and thymic carcinoma
by: Yang Wang, et al.
Published: (2019-01-01)

Immunotherapy for Management of Thymic Epithelial Tumors: A Double-Edged Sword
by: Madison Ballman, et al.
Published: (2022-04-01)

Thymic Epithelial Tumors: An Evolving Field
by: Elisabetta Kuhn, et al.
Published: (2023-01-01)

Chemotherapy in the treatment of thymic tumors
by: Marcello Tiseo, et al.
Published: (2011-12-01)

Chinese expert consensus on the diagnosis and treatment of thymic epithelial tumors
by: Chunwei Xu, et al.
Published: (2023-04-01)

Novel biologic therapies for thymic epithelial tumors
by: YUANBIN eCHEN, et al.
Published: (2014-05-01)

Unraveling the Immune Microenvironment of Thymic Epithelial Tumors: Implications for Autoimmunity and Treatment
by: Christos Masaoutis, et al.
Published: (2022-07-01)

Thymic Epithelial Tumor and Immune System: The Role of Immunotherapy
by: Matteo Perrino, et al.
Published: (2023-11-01)

Thymoma and thymic carcinoma associated with multilocular thymic cyst: a clinicopathologic analysis of 18 cases
by: Xuxia Shen, et al.
Published: (2018-06-01)

What Have We Learned from Molecularly Informed Clinical Trials on Thymomas and Thymic Carcinomas—Current Status and Future Directions?
by: Rohan Maniar, et al.
Published: (2024-01-01)

Can the Ratio SUVmax of the Lesion/SUVmax of Mediastinal Tissues Guide the Choice of Surgical Access for the Resection of Thymic Epithelial Tumors?
by: Sotirios D. Moraitis, et al.
Published: (2022-03-01)

Structural and Functional Thymic Biomarkers Are Involved in the Pathogenesis of Thymic Epithelial Tumors: An Overview
by: Enzo Gallo, et al.
Published: (2022-05-01)

Autoimmune Disease in Patients With Advanced Thymic Epithelial Tumors
by: Surbhi Singhal, MD, et al.
Published: (2022-05-01)

Immune biomarkers in thymic epithelial tumors: expression patterns, prognostic value and comparison of diagnostic tests for PD-L1
by: Isabelle Rouquette, et al.
Published: (2019-12-01)

Searching for Novel Biomarkers in Thymic Epithelial Tumors: Immunohistochemical Evaluation of Hippo Pathway Components in a Cohort of Thymic Epithelial Tumors
by: Kostas Palamaris, et al.
Published: (2023-07-01)

Diagnostic Challenges in the Cytology of Thymic Epithelial Neoplasms
by: Jonathan Willner, et al.
Published: (2022-04-01)

An Overview on Molecular Characterization of Thymic Tumors: Old and New Targets for Clinical Advances
by: Valentina Tateo, et al.
Published: (2021-04-01)

Epigenetics of Thymic Epithelial Tumors
by: Vanessa Nicolì, et al.
Published: (2023-01-01)

The Never-Ending History of Octreotide in Thymic Tumors: A Vintage or A Contemporary Drug?
by: Liliana Montella, et al.
Published: (2022-02-01)

Evaluation of Surgical Therapy in Advanced Thymic Tumors
by: Till Markowiak, et al.
Published: (2021-09-01)

“Radiotherapy for thymic epithelial tumors: What is the optimal dose? A systematic review.”
by: A. Angrisani, et al.
Published: (2022-05-01)

Single Centre Experience in the Management of Thymic Tumours
by: Muhammad Farooq Latif, et al.
Published: (2013-01-01)

Unraveling molecular networks in thymic epithelial tumors: deciphering the unique signatures
by: Xiao Zhang, et al.
Published: (2023-10-01)

Thymic carcinoma with myasthenia gravis：A case report
by: Zheng-Hong Wang, et al.
Published: (2023-06-01)

Thymic Epithelial Tumors as a Model of Networking: Development of a Synergistic Strategy for Clinical and Translational Research Purposes
by: Enrico Melis, et al.
Published: (2020-07-01)

Hadrontherapy for Thymic Epithelial Tumors: Implementation in Clinical Practice
by: Pierre Loap, et al.
Published: (2021-10-01)

Thymic Carcinoma: Unraveling Neuroendocrine Differentiation and Epithelial Cell Identity Loss
by: Yosuke Yamada, et al.
Published: (2023-12-01)

Masaoka-Koga and TNM Staging System in Thymic Epithelial Tumors: Prognostic Comparison and the Role of the Number of Involved Structures
by: Marco Chiappetta, et al.
Published: (2021-10-01)

Small molecule multitarget antiangiogenic inhibitor treatments for advanced thymic epithelial tumors: A retrospective study
by: Wanji Shen, et al.
Published: (2024-01-01)

Optimal management of thymic malignancies: current perspectives
by: Drevet G, et al.
Published: (2019-07-01)